|
| HYDRIDE-L Basic information |
Product Name: | HYDRIDE-L | Synonyms: | HYDRIDE-L;(+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one;BP-2 (LT-EDI);BP-2 (LT-EDI)(Bimaprost、Latanprost);(3aR,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one;2H-Cyclopenta[b]furan-2-one,hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-,(3aR,4R,5R,6aS)-;(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-2-one;Lactondiol B | CAS: | 41639-74-1 | MF: | C18H22O4 | MW: | 302.36 | EINECS: | | Product Categories: | | Mol File: | 41639-74-1.mol | |
| HYDRIDE-L Chemical Properties |
Boiling point | 509.2±50.0 °C(Predicted) | density | 1.286±0.06 g/cm3(Predicted) | storage temp. | 2-8°C | pka | 14.16±0.20(Predicted) |
| HYDRIDE-L Usage And Synthesis |
Uses | PGX 9 is a useful intermediate in the chemoenzymatic synthesis of Latanoprost and Bimatoprost, that are prostaglandin analogs widely used for glaucoma treatment. |
| HYDRIDE-L Preparation Products And Raw materials |
Raw materials | 2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-, (3aR,4R,5R,6aS)--->[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl] -2-oxo-2H-cyclopenta[b]furan-5-yl ester-->Dimethyl (2-oxo-4-phenylbutyl)phosphonate | Preparation Products | Latanoprost Lactone Diol |
|